Expect 35-40% upside in FDC: Gorashekhar

Gorashekhar told CNBC-TV18, "In midcap space we like a pharmaceutical company called FDC. FDC has a very strong business model. It has a turnover close to about Rs 600-650 crore. The company has been like a typical Indian MNC; very strong dividend paying company in fact that last five years dividends have exceeded in excess of 100-150%.”

He further added, “The company has a very strong line-up in nutritional and typically in the unregulated space. For FY10 the roughly EPS is of Rs 8 and close to Rs 10 for FY11. We feel that this stock can give an upside of 35-40% if somebody takes a medium-term delivery call for 6-8 months.”

At 13:25 hrs the share was quoting at Rs 79.20, up Rs 2.45, or 3.19%. Its Market Cap stands at Rs 1,475.33 crore. The company's trailing 12-month (TTM) EPS was at Rs 6.58 per share.